plainslash9

About

A new multicentre randomised cycle Three demo researching pembrolizumab vs . single-agent chemotherapy pertaining to innovative pre-treated cancerous pleural mesothelioma: the ecu Thoracic Oncology Program (ETOP 9-15) PROMISE-meso trial.